Skip to main content
OpenTrials
Completed

NCT Number: NCT05466721

Evaluate Safety and Efficacy of Innovative Medical Devices for Colostomy Patients

The surgical ostomy process happens when it is necessary to open an organ (such as the intestine) in order to maintain a communication channel with the external environment. The need for ostomy surgery can happen as a result of illness, genetic factors, or trauma. Despite the extensive improvements in colorectal surgery, in case there is a need for total or partial extraction and exteriorization of the large intestine (colostomy), it is often necessary to perform a stoma that connects the end of the preserved intestine to the skin, in which cases it is necessary to place a a colostomy bag for stool collection. Thus, there is a substantial number of patients who need to live with a permanent abdominal stoma that significantly affects their quality of life, implying significant changes, both physical and social. It will then be necessary for patients to adjust their daily routines in order to deal with stoma care.

The primary objective of this study is to evaluate the Hydrustoma C3 medical devices (plate C3, capsule C3, night bag C3) in terms of its efficacy and safety as colostomy devices. It is also a primary objective of this study to compare the health-related quality of life in patients with colostomy when using a control and Hydrustoma C3 devices.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Colostomy Stoma

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Da Senhora Da Oliveira - Guimarães, Guimarães, Braga District, Portugal

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Written informed consent;
  • Male and Female patients;
  • Adult aged ≥ 18;
  • Descending and sigmoid colostomy created more than 3 months previously to the beginning of the study;
  • Having formed stool and using a flat ostomy appliance;
  • Able to understand the study procedures and fill questionaries;
  • Able to apply and remove the ostomy device autonomously.

Exclusion criteria

  • Repeated experiences of leakage with the usual ostomy device,
  • Chronically liquid stools,
  • Peristomal skin disorders,
  • Known allergic reactions to components of the device,
  • Receiving chemotherapy, radiation therapy or steroids in the previous month

Treatment and study plan

Hydrustoma C3

Device

The participant will use the device for 14 days.

Coloplast Alterna

Device

The participant will use the device for 14 days.

Primary outcomes

  1. Efficacy of the device (journal of capsule/bag changes)

    Time frame: 14 days

    Efficacy will be accessed by asking patients to record on a journal/diary, for each capsule/bag change, what was the reason for the change, and the occurrence and level of leakage.

  2. Quality of life of the participant (Stoma Quality of Life questionnaire)

    Time frame: 14 days

    In order to compare stoma related quality of life in patients with colostomy when using a control device and the Hydrustoma C3 devices the Stoma Quality of Life questionnaire will be used. This questionnaire is composed of 20 questions. Example of question "I worry that the bag detaches.". All questions must be answered on a scale of 1 to 4, being 1 always and 4 never.

  3. Adverse effects

    Time frame: 14 days

    Safety evaluations will be done by monitoring adverse events.

  4. Safety of the device (Discolouration, Erosion, Tissue overgrowth score)

    Time frame: 14 days

    Safety evaluations will be done by monitoring the peristomal skin using the validated Ostomy Skin tool (DET score). The DET Score is calculated by examining the peristomal skin and evaluate the skin based on the descriptions in each of the 3 domains, discolouration (D), erosion (E) and tissue overgrowth (T); and assessing the size of the area affected in each of the 3 domains. The total score is (maximum 15) calculated by adding all of the subscores from each domain together.

Secondary outcomes

  1. Satisfaction of the participant (questionnaire)

    Time frame: 14 days

    The patients will be asked to evaluate the medical device in terms of application, discretion of the device, stoma related noise, feelings of security (confidence) and overall satisfaction of use (including comfort and impact on body image). The questionnaire has 8 questions of multiple choice (example "Regarding the safety during usage of the devices, I feel: (1) very insecure; (2) moderately insecure; (3) Moderadately secure; (4) Very secure") and 1 open answer question.

Sponsors and collaborators

Lead sponsor

Hydrumedical

Industry

Registry information

Official study title

HydrustomaC3 - Randomized Clinical Trial to Evaluate Safety and Efficacy of Innovative Medical Devices for Colostomy Patients

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jul 20, 2022
Registry last updated
Jan 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.